title: Acute stroke therapy: beyond i.v. tPA.
abstract: Although intravenous tissue plasminogen activator (i.v. tPA) has been approved for treating acute ischemic stroke, it must be given within 3 hours of stroke onset and only after ruling out hemorrhagic stroke by computed tomography. Several medical centers are turning to angiography to guide intra-arterial infusion of thrombolytic agents and mechanical endovascular interventions.
authors.affiliation: Cerebrovascular Center, Department of Neurology, The Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Furlan
mesh_terms: D017130:Angioplasty; D002543:Cerebral Hemorrhage / Q000209:etiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007036:Hypothermia, Induced; D007275:Injections, Intravenous; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000175:diagnosis / Q000628:therapy*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator